Natixis Advisors, L.P.
- SEC CIK
- 0001018331
- Latest filing
- Aug 14, 2026
MYGN holding history
Myriad Genetics Inc in every 13F filed by Natixis Advisors, L.P., including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
MYGN overviewAll 13F holders of MYGNFull Q2 2026 holdings
- Shares (Q2 2025)
- 0
- Sold out in Q2 2025
- Value
- $0
- % of portfolio
- 0.0%
- Quarters held
- 13
- Since Q1 2022
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2025 | 0 | $0 | 0.0% | −212,138−100.0% | Sold out | Holders |
| Q1 2025 | 212,138 | $1.88M | <0.1% | +2,810+1.3% | Added | Holders |
| Q4 2024 | 209,328 | $2.87M | <0.1% | −110,685−34.6% | Reduced | Holders |
| Q3 2024 | 320,013 | $8.77M | <0.1% | +44,646+16.2% | Added | Holders |
| Q2 2024 | 275,367 | $6.74M | <0.1% | +37,002+15.5% | Added | Holders |
| Q1 2024 | 238,365 | $5.08M | <0.1% | +48,087+25.3% | Added | Holders |
| Q4 2023 | 190,278 | $3.64M | <0.1% | +58,449+44.3% | Added | Holders |
| Q3 2023 | 131,829 | $2.12M | <0.1% | −6,695−4.8% | Reduced | Holders |
| Q2 2023 | 138,524 | $3.21M | <0.1% | +29,645+27.2% | Added | Holders |
| Q1 2023 | 108,879 | $2.53M | <0.1% | +50,773+87.4% | Added | Holders |
| Q4 2022 | 58,106 | $843.0K | <0.1% | +5,538+10.5% | Added | Holders |
| Q3 2022 | 52,568 | $1.00M | <0.1% | +34,873+197.1% | Added | Holders |
| Q2 2022 | 17,695 | $322.0K | <0.1% | +2,938+19.9% | Added | Holders |
| Q1 2022 | 14,757 | $372.0K | <0.1% | +14,757 | New | Holders |